Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1995
Revenue	50.22	52.28	49.05	42.18	46.9	Upgrade
Revenue Growth (YoY)	-3.93%	6.58%	16.30%	-10.08%	11.68%	Upgrade
Cost of Revenue	20.19	20.09	18.14	16.63	17.44	Upgrade
Gross Profit	30.04	32.2	30.92	25.55	29.47	Upgrade
Selling, General & Admin	12.7	11.91	11.51	11.35	11.35	Upgrade
Research & Development	0.56	0.49	0.53	0.49	0.48	Upgrade
Operating Expenses	13.26	12.41	12.04	11.84	11.83	Upgrade
Operating Income	16.78	19.79	18.88	13.71	17.63	Upgrade
Other Expense / Income	-3.31	-0.87	-0.18	-0.13	-0.25	Upgrade
Pretax Income	20.09	20.66	19.06	13.84	17.88	Upgrade
Income Tax	3.45	4.19	4.27	3.04	3.16	Upgrade
Net Income	16.64	16.47	14.79	10.8	14.73	Upgrade
Net Income Growth	0.98%	11.39%	36.95%	-26.68%	-20.63%	Upgrade
Shares Outstanding (Basic)	4	4	4	4	4	Upgrade
Shares Change	0.05%	-0.64%	0.29%	-2.17%	-0.35%	Upgrade
EPS (Basic)	4.58	4.53	4.05	2.95	3.96	Upgrade
EPS (Diluted)	4.57	4.52	4.04	2.94	3.94	Upgrade
EPS Growth	1.11%	11.88%	37.41%	-25.38%	-20.40%	Upgrade
Free Cash Flow	21.64	20.34	20.65	19.28	16.52	Upgrade
Free Cash Flow Per Share	5.96	5.61	5.66	5.29	4.44	Upgrade
Dividend Per Share	1.185	1.165	2.855	1.125	1.105	Upgrade
Dividend Growth	1.72%	-59.19%	153.78%	1.81%	1.84%	Upgrade
Gross Margin	59.81%	61.58%	63.03%	60.57%	62.82%	Upgrade
Operating Margin	33.40%	37.85%	38.49%	32.50%	37.59%	Upgrade
Profit Margin	33.12%	31.51%	30.15%	25.60%	31.40%	Upgrade
Free Cash Flow Margin	43.09%	38.90%	42.10%	45.70%	35.21%	Upgrade
Effective Tax Rate	17.19%	20.26%	22.42%	21.98%	17.65%	Upgrade
EBITDA	26.46	27.74	26.35	21.05	24.77	Upgrade
EBITDA Margin	52.68%	53.06%	53.71%	49.91%	52.80%	Upgrade
Depreciation & Amortization	6.37	7.08	7.28	7.21	6.88	Upgrade
EBIT	20.09	20.66	19.06	13.84	17.88	Upgrade
EBIT Margin	40.00%	39.52%	38.86%	32.81%	38.13%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).